Meet our team

In order to accelerate oncology innovation and asset commercialisation we have built a team of experts who have not only successfully achieved this in their careers to date but who are committed to contributing their experience and expertise to continued innovation and success in oncology drug development both now and in the future

The cross-functional team at Cumulus are individually and collectively exceptional scientists and entrepreneurs in the oncology area, many with successful drug development programmes to their name. This blend of scientific acumen, commercial understanding coupled with proven operational ability blends powerfully with the shared purpose of the team; to innovate in oncology drug discovery and development to ensure that only the most promising scientific discoveries are translated into new therapeutic options for cancer patients.

Board of Directors

Dr Russell Greig
Chairman

Extensive biotech & VC investment experience

LinkedIn

Dr Clare Wareing
Founder & CEO

Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.

LinkedIn

Dr Sally Waterman
NED

Entrepreneur and biotech industry veteran with extensive drug development, commercialisation and board experience. Company builder.

LinkedIn

Dr Diane Seimetz
NED

Entrepreneur and expert in the development and commercialisation of biologics. Company builder.

LinkedIn

Dr Andrew McNeill PhD
Investor Director

Serial entrepreneur and investor in the technology and life sciences sector. Expertise in company spin-outs, deal structure, investment and exit strategies. Company builder.

LinkedIn

Mr Keith Murdoch
Chief Financial Officer (Director)

Entrepreneur and investment strategist. Expertise in deal negotiation and M&A activities as well as investor relations, financial modelling and business management.

LinkedIn

Clare Doris
Chief Operating Officer

A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.

LinkedIn

Cumulus Core Team

Dr Clare Wareing
Founder & CEO

Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.

LinkedIn

Clare Doris
Chief Operating Officer

A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.

LinkedIn

Dr Ian Waddell
Chief Scientific Officer

Oncology focussed biochemist with more than 25 years’ experience and a proven track record of drug discovery in a variety of settings including large pharma, academic and CRO. Has interests in target identification / validation and synthetic lethal and epigenetics.

LinkedIn

Scott Doak
Group Finance Director

Entrepreneurial financial strategist with extensive experience of financial modelling and business management, deal negotiation and investor relations.

LinkedIn

Dr Nikki March
Senior Director of Scientific Affairs

Highly skilled scientist, with over 20 years’ experience in the oncology area, spanning molecular signalling, signal transduction pathways and applications in drug discovery.

LinkedIn

Manuelle Debunne PhD
Director of Scientific Affairs

Entrepreneurial scientist with proven ability to manage academic and industry programs to translate oncology assets towards clinical development.

LinkedIn

Daragh Campbell
Project Manager

Entrepreneurial scientist with industrial management experience to support executive and commercial teams.

LinkedIn

Arlene Davie
Admin

Experienced Office Manager with a demonstrated history of working in the biotechnology industry. Strong administrative professional with over 30 years experience.

LinkedIn

We are hiring

Want to be part of a mission-led company in oncology drug development?